Drug intelligence / Profile preview

fluconazole + tinidazole

Development stage
Unknown
Lead developer
Chem Med Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Fluconazole + tinidazole is a fixed-dose combination anti-infective medication developed by Chem Med Pharmaceuticals. It combines fluconazole, a triazole antifungal, with tinidazole, a nitroimidazole derivative. Fluconazole works by inhibiting the fungal enzyme lanosterol 14-alpha demethylase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. Tinidazole acts as an antiprotozoal and antibacterial agent; it is reduced within the target organism to form free radicals that cause DNA strand breakage and inhibit nucleic acid synthesis. This combination is primarily indicated for the treatment of mixed vaginal infections, such as those involving Candida species, Trichomonas vaginalis, and anaerobic bacteria. It is administered orally, typically as a single dose or a short course, and is approved for use in treating various forms of vaginitis and associated fungal or protozoal infections.

Brand names
Afumix
Other names
Fluconazole 150mg / Tinidazole 750mg combinationFluconazoleTinidazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)DNA

Beyond the preview

Go deeper on fluconazole + tinidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluconazole + tinidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call